Reviva Pharmaceuticals RVPH
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 1.81 | 100.56 | -0.15 | -6,285 | -6 | |
| 2024Q3 | 1.44 | 101.22 | -0.24 | -8,463 | -8 | |
| 2024Q2 | 1.28 | 103.59 | -0.26 | -8,130 | -8 | |
| 2024Q1 | 3.78 | 106.72 | -0.25 | -7,922 | -7 | |
| 2023Q4 | 5.15 | 102.55 | -0.33 | -9,619 | -9 | |
| 2023Q3 | 4.88 | 102.10 | -0.48 | -11,195 | -11 | |
| 2023Q2 | 5.86 | 97.10 | -0.53 | -11,821 | -12 | |
| 2023Q1 | 4.19 | 102.18 | -0.31 | -6,736 | -7 | |
| 2022Q4 | 4.25 | 95.86 | -0.58 | -7,774 | -8 | |
| 2022Q3 | 1.59 | 101.42 | -0.18 | -3,563 | -4 | |
| 2022Q2 | 1.10 | 103.49 | -0.29 | -5,519 | -5 | |
| 2022Q1 | 2.46 | 101.21 | -0.40 | -7,450 | -7 | |
| 2021Q4 | 2.89 | 107.60 | -0.22 | -3,965 | -4 | |
| 2021Q3 | 4.07 | 108.78 | -0.13 | -2,477 | -2 | |
| 2021Q2 | 4.86 | 111.59 | -0.13 | -1,791 | -2 | |
| 2021Q1 | 5.74 | 197.47 | -0.10 | -1,872 | -1 | |
| 2020Q4 | 8.75 | -527 | -2 | |||
| 2020Q3 | 10.75 | 101.15 | -0.04 | -352 | 0 | |
| 2020Q2 | 101.94 | -0.19 | -526 | -1 | ||
| 2020Q1 | 169.87 | -0.09 | -265 | 0 |